Flash FinanceUS
Market open S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · 21Shares XRP ETF (TOXR)

21Shares XRP ETF to end CF Benchmarks pricing license, effective Aug. 31, 2026

Neutral Impact 3 of 5 product/contract Written later

The Sponsor, 21Shares US LLC, notified CF Benchmarks on June 30, 2026 that it is terminating the licensing agreement for the XRP pricing benchmark used to value the Trust's shares and calculate its net asset value, effective August 31, 2026. The Sponsor plans to replace it with a licensing agreement with FTSE International Limited on or about August 24, 2026, as part of a broader move to a new benchmark provider.

Key points

  • Notice of termination given to CF Benchmarks on June 30, 2026; termination effective August 31, 2026
  • Terminated agreement covers the CME CF XRP-Dollar Reference Rate, New York Variant, used daily for share valuation and NAV
  • Sponsor intends to license FTSE index data on or about August 24, 2026, with a one-year initial term that renews automatically

The filing

Company21Shares XRP ETF (TOXR)
Form8-K, current report
Filed with the SECJul 7, 2026, 4:31 PM ET
Accession number0001213900-26-075988

Items reported: 1.02 Termination of Material Agreement

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 11:46 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on July 07, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.